In the lung, OE-MRI is primarily used to assess regional ventilation and oxygen transfer. When different concentrations of oxygen are inhaled, signal changes can be detected in ventilated regions of the lung, providing a map of how effectively oxygen reaches different areas of the pulmonary parenchyma.
Depending on the MR sequence used, both T1 and T2* changes may be observed. These responses can be quantified in several ways, including relative signal enhancement or direct quantification of changes in T1 or T2*. From these measures, metrics such as ventilation defect percentage can be derived, indicating the extent of lung tissue that is not effectively ventilated.
OE-MRI reveals spatial heterogeneity in ventilation and oxygen delivery that structural imaging alone does not show. This is particularly relevant in diseases where regional lung function is locally impaired rather than uniformly reduced, including chronic obstructive pulmonary disease, asthma, cystic fibrosis, and other respiratory conditions.
A major strength of lung OE-MRI is that it provides functional information without ionising radiation and without injected contrast agent. This makes it well suited to repeat imaging studies, paediatric populations, therapy assessment, and research applications where safe and non-invasive measurement of regional lung function is a priority.